By the Numbers
In seven years, MaRS Innovation’s team has assessed 1,400 disclosures, created 37 companies and taken an additional 100 technologies under management.
Of our companies, 36 are still located in Canada. Collectively, they’ve attracted $125 million in external investment with $95 million coming from outside of Canada, and have created over 300 direct jobs.
Angel investors and venture firms investing in our portfolio hail from China, Germany, Hong Kong, the Kingdom of Saudi Arabia, the Netherlands, the United Kingdom and the United States.
Our industry partners in the life sciences include Baxter, GSK, Johnson & Johnson, LifeLabs, Merck and Pfizer.